Gliomas with high TANK levels exhibited enrichment in immunomodulatory pathways, including “hypoxia”, “angiogenesis”, “inflammatory response”, “NF-kappaB signaling”, and “IL6/STAT3 signaling” in the TCGA cohort (Figure 3B). The gene discussed is IL6; the disease is glioma.